AllllSevens
Stock-Market Research, Institutional Trading & Market Inefficiencies
IREN looks horrendous on the chart, but institutions are not selling, setting up a big pop to $40+ once everyone gives up. The declines have come on a complete lack of volume. Over the first half of 2026 it saw $250B of high-volume activity and twice failed to make new lows in this area, a textbook long-term accumulation campaign; key institutional supports above still need to be reclaimed to confirm a short-term bullish trend. x.com x.comÂ
IREN is still under a long-term institutional accumulation campaign, with textbook inefficient selling off every high. Over the high-volume zone built in the first half of 2026, the stock has failed to make new lows for the second time in this area. Some key institutional supports above still need to be reclaimed to fully confirm a renewed short-term bullish trend, so it stays on watch. x.comÂ
Open-source models likely wrecked the heavy-capex thesis behind IREN. Debt CDS and falling token prices make the still-bullish view definitely less so. Unlike Roku, a previous long-term hold with a unique, massive user base, low capex and positive free cash flow, IREN lacks a clear path forward; without one, it is better not to hold it. If Warsh remains hawkish, a full exit from IREN is very likely. x.com x.comÂ
IREN's long-term appeal rests on its standing as one of the best vertically integrated AI neoclouds. In the short term, the stock has not been this oversold since 2022. x.comÂ
IREN is not yet a buy after breaking out of its channel to the downside and still searching for support near $35: negative dealer gamma around current levels can amplify moves in either direction. A base is needed before reconsidering the earlier conditional upside. x.comÂ
IREN's $8 billion in cash against a valuation of just $10 billion points to unfathomable upside potential. Its shares are back below their $28 IPO price. x.comÂ
IREN looks cheap below $35 and is favored over DigitalOcean, whose stock looks bubbly against an estimated $110 value despite its appeal as a business. A switch toward IREN is under consideration if things go well. x.com x.comÂ
IREN's predatory management and markedly weaker execution than Nebius make it hard to take seriously while Mike Alfred remains on its board. Barring an oversold bounce, IREN looks cooked big time with more time. x.com x.comÂ
IREN looks good, with a lot of bullish options activity in the stock. x.comÂ
IREN's forecast revenue ramp underpins the $100-plus share-price view. It will do $4 billion in ARR by Q1 and $13 billion by the end of next year; comparing today's share price and shares outstanding with its IPO overlooks that expected growth. x.com x.comÂ
IREN's worsening fundamentals warrant patience despite its potential. Trailing free cash flow is -$2.45 billion, net income -$703 million and EPS -$1.64 even as revenue has grown; it needs a catalyst change and a positive trend in fundamentals. x.comÂ
IREN lacks a near-term catalyst strong enough to drive a real move to new highs, yet this is a level to buy, not sell. IREN's Dan Roberts suggested deals should not be expected soon, and anything short of a deal likely brings only a small pop and fade. The risk is subpar November earnings and no deal before February results, since the chart cannot afford a five-month fade. x.com x.com x.com x.comÂ
